Carbohydrate binding molecules in malaria pathology

Current Opinion in Structural Biology

Volumn 20, Issue 5, 2010, Pages 560-566

  Brown, Alan ^a   Higgins, Matthew K ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; CELL ANTIGEN; CHONDROITIN 4 SULFATE; DUFFY BINDING PROTEIN; DUFFY BINDING PROTEIN 3C; DUFFY BINDING PROTEIN 6EPSILON; ERYTHROCYTE BINDING ANTIGEN 175; ERYTHROCYTE MEMBRANE PROTEIN 1; FUNGAL PROTEIN; GLYCOPHORIN A; UNCLASSIFIED DRUG; VAR2 CHONDROITIN 4 SULFATE;

BINDING SITE; CARBOHYDRATE ANALYSIS; CELL ADHESION; CELL INVASION; CRYSTAL STRUCTURE; ERYTHROCYTE; MALARIA; NONHUMAN; PLACENTA; PLASMODIUM; PLASMODIUM (LIFE CYCLE STAGE); PLASMODIUM FALCIPARUM; PLASMODIUM REICHENOWI; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW;

ANIMALS; CARBOHYDRATE METABOLISM; CELL ADHESION; ERYTHROCYTES; HUMANS; MALARIA; N-ACETYLNEURAMINIC ACID; PLASMODIUM FALCIPARUM;

PLASMODIUM FALCIPARUM;

EID: 78049436508     PISSN: 0959440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sbi.2010.06.008     Document Type: Review

References (48)

1. Miller L.H., Baruch D.I., Marsh K., Doumbo O.K. The pathogenic basis of malaria. Nature 2002, 415:673-679.
2. Cowman A.F., Crabb B.S. Invasion of red blood cells by malaria parasites. Cell 2006, 124:755-766.
3. Iyer J., Grüner A.C., Rénia L., Snounou G., Preiser P.R. Invasion of host cells by malaria parasites: a tale of two protein families. Mol Microbiol 2007, 65:231-249.
4. Sim B.K., Chitnis C.E., Wasniowska K., Hadley T.J., Miller L.H. Receptor and ligand domains for invasion of erythrocytes by Plasmodium falciparum. Science 1994, 264:1941-1944.
5. Duraisingh M.T., Maier A.G., Triglia T., Cowman A.F. Erythrocyte-binding antigen 175 mediates invasion in Plasmodium falciparum utilizing sialic acid-dependent and -independent pathways. Proc Natl Acad Sci U S A 2003, 100:4796-4801.
6. Ockenhouse C.F., Barbosa A., Blackall D.P., Murphy C.I., Kashala O., Dutta S., Lanar D.E., Daugherty J.R. Sialic acid-dependent binding of baculovirus-expressed recombinant antigens from Plasmodium falciparum EBA-175 to Glycophorin A. Mol Biochem Parasitol 2001, 113:9-21.
7. Narum N.L., Haynes J.D., Fuhrmann S.R., Luu S.T., Sim B.K. Antibodies against the Plasmodium falciparum receptor binding domain of EBA-175 block invasion pathways that do not involve sialic acids. Infect Immun 2000, 68:1964-1966.
8. Pandey K.C., Singh S., Pattnaik P., Pillai C.R., Pillai U., Lynn A., Jain S.K., Chitnis C.E. Bacterially expressed and refolded receptor binding domain of Plasmodium falciparum EBA-175 elicits invasion inhibitory antibodies. Mol Biochem Parasitol 2002, 123:23-33.
9. Maier A.G., Baum J., Smith B., Conway D.J., Cowman A.F. Polymorphisms in erythrocyte binding antigens 140 and 181 affect function and binding but not receptor specificity in Plasmodium falciparum. Infect Immun 2009, 77:1689-1699.
10. Orlandi P.A., Sim B.K., Chulay J.D., Haynes J.D. Characterization of the 175-kilodalton erythrocyte binding antigen of Plasmodium falciparum. Mol Biochem Parasitol 1990, 40:285-294.
11. Orlandi P.A., Klotz F.W., Haynes J.D. A malaria invasion receptor, the 175-kilodalton erythrocyte binding antigen of Plasmodium falciparum recognizes the terminal Neu5Ac(alpha 2-3)Gal sequences of glycophorin A. J Cell Biol 1992, 116:901-909.
12. Wang H.Y., Tang H., Shen C.K., Wu C.I. Rapidly evolving genes in human. I. The glycophorins and their possible role in evading malaria parasites. Mol Biol Evol 2003, 20:1795-1804.
13. Baum J., Ward R.H., Conway D.J. Natural selection on the erythrocyte surface. Mol Biol Evol 2002, 19:223-229.
14. Rich S.M., Leendertz F.H., Xu G., LeBreton M., Djoko C.F., Aminake M.N., Takang E.E., Diffo J.L., Pike B.L., Rosenthal B.M., et al. The origin of malignant malaria. Proc Natl Acad Sci U S A 2009, 106:14902-14907.
15. Martin M.J., Rayner J.C., Gagneux P., Barnwell J.W., Varki A. Evolution of human-chimpanzee differences in malaria susceptibility: relationship to human genetic loss of N-glycolylneuraminic acid. Proc Natl Acad Sci U S A 2005, 102:12819-12824.
16. Tolia N.H., Enemark E.J., Sim B.K., Joshua-Tor L. Structural basis for the EBA-175 erythrocyte invasion pathway of the malaria parasite Plasmodium falciparum. Cell 2005, 122:183-193.
17. Liang H., Sim B.K. Conservation of structure and function of the erythrocyte-binding domain of Plasmodium falciparum EBA-175. Mol Biochem Parasitol 1997, 84:241-245.
18. Baum J., Pinder M., Conway D.J. Erythrocyte invasion phenotypes of Plasmodium falciparum in The Gambia. Infect Immun 2003, 71:1856-1863.
19. Verra F., Chokejindachai W., Weedall G.D., Polley S.D., Mwangi T.W., Marsh K., Conway D.J. Contrasting signatures of selection on the Plasmodium falciparum erythrocyte binding antigen gene family. Mol Biochem Parasitol 2006, 149:182-190.
20. Reed M.B., Caruana S.R., Batchelor A.H., Thompson J.K., Crabb B.S., Cowman A.F. Targeted disruption of an erythrocyte binding antigen in Plasmodium falciparum is associated with a switch toward a sialic acid-independent pathway of invasion. Proc Natl Acad Sci U S A 2000, 97:7509-7514.
21. Bachmann A., Esser C., Petter M., Predehl S., von Kalckreuth V., Schmiedel S., Bruchhaus I., Tannich E. Absence of erythrocyte sequestration and lack of multicopy gene family expression in Plasmodium falciparum from a splenectomized malaria patient. PLoS One 2009, 4:e7459.
22. Fried M., Nosten F., Brockman A., Brabin B.J., Duffy P.E. Maternal antibodies block malaria. Nature 1998, 395:851-852.
23. Hviid L. The role of Plasmodium falciparum variant surface antigens in protective immunity and vaccine development. Hum Vaccin 2010, 6:84-89.
24. Gardner M.J., Hall N., Fung E., White O., Berriman M., Hyman R.W., Carlton J.M., Pain A., Nelson K.E., Bowman S., et al. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 2002, 419:498-511.
25. Smith J.D., Chitnis C.E., Craig A.G., Roberts D.J., Hudson-Taylor D.E., Peterson D.S., Pinches R., Newbold C.I., Miller L.H. Switches in expression of Plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes. Cell 1995, 82:101-110.
26. Ockenhouse C.F., Tandon N.N., Magowan C., Jamieson G.A., Chulay J.D. Identification of a platelet membrane glycoprotein as a falciparum malaria sequestration receptor. Science 1989, 243:1469-1471.
27. Chakravorty S.J., Craig A. The role of ICAM-1 in Plasmodium falciparum cytoadherence. Eur J Cell Biol 2005, 84:15-27.
28. Barragan A., Fernandez V., Chen Q., von Euler A., Wahlgren M., Spillmann D. The Duffy-binding-like domain 1 of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) is a heparan sulfate ligand that requires 12mers for binding. Blood 2000, 95:3594-3599.
29. Vogt A.M., Barragan A., Chen Q., Kironde F., Spillmann D., Wahlgren M. Heparan sulfate on endothelial cells mediates the binding of Plasmodium falciparum-infected erythrocytes via the DBL1alpha domain of PfEMP1. Blood 2003, 101:2405-2411.
30. Hviid L., Salanti A. VAR2CSA and protective immunity against pregnancy-associated Plasmodium falciparum malaria. Parasitology 2007, 134:1871-1876.
31. Salanti A., Staalsoe T., Lavstsen T., Jensen A.T., Sowa M.P., Arnot D.E., Hviid L., Theander T.G. Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malaria. Mol Microbiol 2003, 49:179-191.
32. Fried M., Duffy P.E. Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta. Science 1996, 272:1502-1504.
33. Alkhalil A., Achur R.N., Valiyaveettil M., Ockenhouse C.F., Gowda D.C. Structural requirements for the adherence of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate proteoglycans of human placenta. J Biol Chem 2000, 275:40357-40364.
34. Dahlbäck M., Rask T.S., Andersen P.H., Nielsen M.A., Ndam N.T., Resende M., Turner L., Deloron P., Hviid L., Lund O., et al. Epitope mapping and topographic analysis of VAR2CSA DBL3X involved in P. falciparum placental sequestration. PLoS Pathog 2006, 2:e124.
35. Gamain B., Trimnell A.R., Scheidig C., Scherf A., Miller L.H., Smith J.D. Identification of multiple chondroitin sulfate A (CSA)-binding domains in the var2CSA gene transcribed in CSA-binding parasites. J Infect Dis 2005, 191:1010-1013.
36. Resende M., Ditlev S.B., Nielsen M.A., Bodevin S., Bruun S., Pinto V.V., Clausen H., Turner L., Theander T.G., Salanti A., Dahlback M. Chondroitin sulphate A (CSA)-binding of single recombinant Duffy-binding-like domains is not restricted to Plasmodium falciparum erythrocyte membrane protein 1 expressed by CSA-binding parasites. Int J Parasitol 2009, 39:1195-1220.
37. Higgins M.K. The structure of a chondroitin sulfate-binding domain important in placental malaria. J Biol Chem 2008, 283:21842-21846.
38. Singh K., Gittis A.G., Nguyen P., Gowda D.C., Miller L.H., Garboczi D.N. Structure of the DBL3x domain of pregnancy-associated malaria protein VAR2CSA complexed with chondroitin sulfate A. Nat Struct Mol Biol 2008, 15:932-938.
39. Khunrae P., Philip J.M., Bull D.R., Higgins M.K. Structural comparison of two CSPG-binding DBL domains from the VAR2CSA protein important in malaria during pregnancy. J Mol Biol 2009, 393:202-213.
40. Bockhorst J., Lu F., Janes J.H., Keebler J., Gamain B., Awadalla P., Su X.Z., Samudrala R., Jojic N., Smith J.D. Structural polymorphism and diversifying selection on the pregnancy malaria vaccine candidate VAR2CSA. Mol Biochem Parasitol 2007, 155:103-112.
41. Khunrae P., Dahlbäck M., Nielsen M.A., Andersen G., Ditlev S.B., Resende M., Pinto V., Theander T.G., Higgins M.K., Salanti A. Full-length recombinant Plasmodium falciparum VAR2CSA binds specifically to CSPG and induces potent parasite adhesion blocking antibodies. J Mol Biol 2010, 397:826-834.
42. Srivastava A., Gangnard S., Round A., Dechavanne S., Juillerat A., Raynal B., Faure G., Baron B., Ramboarina S., Singh S.K., et al. Full-length extracellular region of the var2CSA variant of PfEMP1 is required for specific, high-affinity binding to CSA. Proc Natl Acad Sci U S A 2010, 107:4884-4889.
43. Plassmeyer M.L., Reiter K., Shimp R.L., Kotova S., Smith P.D., Hurt D.E., House B., Zou X., Zhang Y., Hickman M., et al. Structure of the Plasmodium falciparum circumsporozoite protein, a leading malaria vaccine candidate. J Biol Chem 2009, 284:26951-26963.
44. Akhouri R.R., Bhattacharyya A., Pattnaik P., Malhotra P., Sharma A. Structural and functional dissection of the adhesive domains of Plasmodium falciparum thrombospondin-related anonymous protein (TRAP). Biochem J 2004, 379:815-822.
45. Rathore D., Hrstka S.C., Sacci J.B., De la Vega P., Linhardt R.J., Kumar S., McCutchan T.F. Molecular mechanism of host specificity in Plasmodium falciparum infection: role of circumsporozoite protein. J Biol Chem 2003, 278:40905-40910.
46. Tossavainen H., Pihlajamaa T., Huttunen T.K., Raulo E., Rauvala H., Permi P., Kilpeläinen I. The layered fold of the TSR domain of P. falciparum TRAP contains a heparin binding site. Protein Sci 2006, 15:1760-1768.
47. Coppi A., Tewari R., Bishop J.R., Bennett B.L., Lawrence R., Esko J.D., Billker O., Sinnis P. Heparan sulfate proteoglycans provide a signal to Plasmodium sporozoites to stop migrating and productively invade host cells. Cell Host Microbe 2007, 2:316-327.
48. Sinnis P., Coppi A., Toida T., Toyoda H., Kinoshita-Toyoda A., Xie J., Kemp M.M., Linhardt R.J. Mosquito heparan sulfate and its potential role in malaria infection and transmission. J Biol Chem 2007, 282:25376-25384.